Commonality in chronic inflammatory diseases: Periodontitis, diabetes, and coronary artery disease

Periodontology 2000

Volumn 40, Issue 1, 2006, Pages 130-143

  Southerland, Janet H ^a   Taylor, George W ^b   Moss, Kevin ^c   Beck, James D ^a   Offenbacher, Steven ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN;

BACTERIAL PHENOMENA AND FUNCTIONS; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; HUMAN; HYPERGLYCEMIA; INFLAMMATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIODONTITIS; PHYSIOLOGY; REVIEW; RISK FACTOR;

BACTERIAL PHYSIOLOGY; CHRONIC DISEASE; CORONARY DISEASE; DIABETES MELLITUS; DISEASE PROGRESSION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERGLYCEMIA; INFLAMMATION; MEMBRANE PROTEINS; NF-KAPPA B; OXIDATIVE STRESS; PERIODONTITIS; RECEPTORS, IMMUNOLOGIC; RISK FACTORS;

EID: 33644862852     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2005.00138.x     Document Type: Review

References (173)

1. Aggarwal BB Takada Y Shishodia S Gutierrez AM Oommen OV Ichikawa H Baba Y Kumar A Nuclear transcription factor NF-kappa B: role in biology and medicine Indian J Exp Biol 2004 42 341 353
2. Alexander CM Landsman PB Teutsch SM Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease Am J Cardiol 2000 86 897 902
3. Alexiewicz JM Kumar D Smogorzewski M Klin M Massry SG Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function Ann Intern Med 1995 123 919 924
4. American Diabetes Association. Direct and indirect costs of diabetes in the United States [WWW document]..
5. Andresen JL Rasmussen LM Ledet T Diabetic macroangiopathy and atherosclerosis Diabetes 1996 45 Suppl. 3 S91 S94
6. Araya AV Pavez V Perez C Gonzalez F Columbo A Aguirre A Schiattino I Aguillon JC Ex vivo lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis Eur Cytokine Netw 2003 14 128 133
7. Arif S Tree TI Astill TP Tremble JM Bishop AJ Dayan CM Roep BO Peakman M Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health J Clin Invest 2004 113 451 463
8. Basta G Schmidt AM De Caterina R Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res 2004 63 582 592
9. Baumann H Jahreis GP Morella KK Interaction of cytokine- and glucocorticoid-response elements of acute-phase plasma protein genes. Importance of glucocorticoid receptor level and cell type for regulation of the elements from rat alpha 1-acid glycoprotein and beta-fibrinogen genes J Biol Chem 1990 265 22275 22281
10. Beauparlant P Hiscott J Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis Cytokine Growth Factor Rev 1996 7 175 190
11. Beck JD Slade G Offenbacher S Oral disease, cardiovascular disease and systemic inflammation Periodontol 2000 2000 23 110 120
12. Beinke S Ley SC Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology Biochem J 2004 382 393 409
13. Blackwell TS Christman JW The role of nuclear factor-kappa B in cytokine gene regulation Am J Respir Cell Mol Biol 1997 17 3 9
14. Bowie A O'Neill LA Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries Biochem Pharmacol 2000 59 13 23
15. Brett J Schmidt AM Yan SD Zou YS Weidman E Pinsky D Nowygrod R Neeper M Przysiecki C Shaw A et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues Am J Pathol 1993 143 1699 1712
16. Broussard SR McCusker RH Novakofski JE Strle K Shen WH Johnson RW Dantzer R Kelley KW IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts J Immunol 2004 172 7713 7720
17. Brownlee M Lilly Lecture 1993. Glycation and diabetic complications Diabetes 1994 43 836 841
18. Brownlee M The pathological implications of protein glycation Clin Invest Med 1995 18 275 281
19. Cairo F Gaeta C Dorigo W Oggioni MR Pratesi C Pini Prato GP Pozzi G Periodontal pathogens in atheromatous plaques. A controlled clinical and laboratory trial J Periodontal Res 2004 39 442 446
20. Cerami A Vlassara H Brownlee M Role of advanced glycosylation products in complications of diabetes Diabetes Care 1988 11 Suppl. 1 73 79
21. Charonis AS Reger LA Dege JE Kouzi-Koliakos K Furcht LT Wohlhueter RM Tsilibary EC Laminin alterations after in vitro nonenzymatic glycosylation Diabetes 1990 39 807 814
22. Chavakis T Bierhaus A Nawroth PP RAGE (receptor for advanced glycation end products): a central player in the inflammatory response Microbes Infect 2004 6 1219 1225
23. Chisolm GM Irwin KC Penn MS Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes Diabetes 1992 41 Suppl. 2 61 66
24. Collison KS Parhar RS Saleh SS Meyer BF Kwaasi AA Hammami MM Schmidt AM Stern DM Al-Mohanna FA RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs) J Leukoc Biol 2002 71 433 444
25. Crofford LJ COX-1 and COX-2 tissue expression: implications and predictions J Rheumatol Suppl 1997 49 15 19
26. de Alvaro C Teruel T Hernandez R Lorenzo M Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner J Biol Chem 2004 279 17070 17078
27. DeGroot J The AGE of the matrix: chemistry, consequence and cure Curr Opin Pharmacol 2004 4 301 305
28. Dinarello CA Mier JW Interleukins Annu Rev Med 1986 37 173 178
29. Di Paola R Marzocco S Mazzon E Dattola F Rotondo F Britti D De Majo M Genovese T Cuzzocrea S Effect of aminoguanidine in ligature-induced periodontitis in rats J Dent Res 2004 83 343 348
30. Doi T Vlassara H Kirstein M Yamada Y Striker GE Striker LJ Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor Proc Natl Acad Sci U S A 1992 89 2873 2877
31. Donald R Ballard DW Hawiger J Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators J Biol Chem 1995 270 9 12
32. Drash AL What do epidemiologic observations tell us about the etiology of insulin dependent diabetes mellitus? Schweiz Med Wochenschr 1990 120 39 45
33. Ellis RW Infection and coronary heart disease J Med Microbiol 1997 46 535 539
34. Esposito K Giugliano D The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004 14 228 232
35. Fahey TJ 3rd, Sadaty A Jones WG 2nd, Barber A Smoller B Shires GT Diabetes impairs the late inflammatory response to wound healing J Surg Res 1991 50 308 313
36. Feingold KR Grunfeld C Role of cytokines in inducing hyperlipidemia Diabetes 1992 41 Suppl. 2 97 101
37. Feingold KR Grunfeld C Pang M Doerrler W Krauss RM LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes Arterioscler Thromb 1992 12 1496 1502
38. Feingold KR Soued M Serio MK Moser AH Dinarello CA Grunfeld C Multiple cytokines stimulate hepatic lipid synthesis in vivo Endocrinology 1989 125 267 274
39. Feingold KR Staprans I Memon RA Moser AH Shigenaga JK Doerrler W Dinarello CA Grunfeld C Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance J Lipid Res 1992 33 1765 1776
40. Ferreri NR Howland WC Spiegelberg HL Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE J Immunol 1986 136 4188 4193
41. Fibbe WE Falkenburg JH Schaafsma MR Willemze R The hematopoietic activities of interleukin-1 Biotherapy 1989 1 263 271
42. Fiske J Diabetes mellitus and oral care Dent Update 2004 31 190-196 198
43. Fox CS Coady S Sorlie PD Levy D Meigs JB D'Agostino RB Sr. Wilson PW Savage PJ Trends in cardiovascular complications of diabetes JAMA 2004 292 2495 2499
44. Gamonal J Acevedo A Bascones A Jorge O Silva A Levels of interleukin-1 beta-8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment J Periodontol 2000 71 1535 1545
45. Garcia-Welsh A Schneiderman JS Baly DL Interleukin-1 stimulates glucose transport in rat adipose cells. Evidence for receptor discrimination between IL-1 beta and IL-1 alpha FEBS Lett 1990 269 421 424
46. Garvey WT Kwon S Zheng D Shaughnessy S Wallace P Hutto A Pugh K Jenkins AJ Klein RL Liao Y Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance Diabetes 2003 52 453 462
47. Ghosh S May MJ Kopp EB NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses Annu Rev Immunol 1998 16 225 260
48. Ginsberg HN Tuck C Diabetes and dyslipidemia Curr Diab Rep 2001 1 93 95
49. Griffith RL Virella GT Stevenson HC Lopes-Virella MF Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation J Exp Med 1988 168 1041 1059
50. Grunfeld C Soued M Adi S Moser AH Dinarello CA Feingold KR Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha Endocrinology 1990 127 46 54
51. Haffner SM Epidemiology of type 2 diabetes: risk factors Diabetes Care 1998 21 Suppl. 3 C3 C6
52. Hallmon WW Mealey BL Implications of diabetes mellitus and periodontal disease Diabetes Educ 1992 18 310 315
53. Hanefeld M Fischer S Julius U Schulze J Schwanebeck U Schmechel H Ziegelasch HJ Lindner J Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up Diabetologia 1996 39 1577 1583
54. Hardardottir I Doerrler W Feingold KR Grunfeld C Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism Biochem Biophys Res Commun 1992 186 237 243
55. Hasegawa T Kosaki A Kimura T Matsubara H Mori Y Okigaki M Masaki H Toyoda N Inoue-Shibata M Kimura Y Nishikawa M Iwasaka T The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages Atherosclerosis 2003 171 211 218
56. Haskill S Beg AA Tompkins SM Morris JS Yurochko AD Sampson-Johannes A Mondal K Ralph P Baldwin AS Jr. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity Cell 1991 65 1281 1289
57. Heinecke JW Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis Am J Cardiol 2003 91 12A 16A
58. Hobbs CG Kodikara M Gray R Bordin P Robinson A Pacy PJ Venkatesan S Halliday D Lipoproteins in non-insulin dependent diabetes mellitus (NIDDM) Biochem Soc Trans 1996 24 153S
59. Hogan P Dall T Nikolov P Economic costs of diabetes in the US in 2003 Diabetes Care 2002 26 917 932
60. Hove KA Stallard RE Diabetes and the periodontal patient J Periodontol 1970 41 713 718
61. Hugoson A Thorstensson H Falk H Kuylenstierna J Periodontal conditions in insulin-dependent diabetics J Clin Periodontol 1989 16 215 223
62. Iehara N Takeoka H Tsuji H Yamada Y Kita T Doi T Advanced glycosylation end products modulate transcriptional regulations on mesangial cells Contrib Nephrol 1996 118 141 146
63. Ishihara K Tsutsumi K Kawane S Nakajima M Kasaoka T The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a d -domain-like docking site FEBS Lett 2003 550 107 113
64. Jang MK Kim JY Jeoung NH Kang MA Choi MS Oh GT Nam KT Lee WH Park YB Oxidized low-density lipoproteins may induce expression of monocyte chemotactic protein-3 in atherosclerotic plaques Biochem Biophys Res Commun 2004 323 898 905
65. Jenkins AJ Lyons TJ Zheng D Otvos JD Lackland DT McGee D Garvey WT Klein RL Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia Diabetes Care 2003 26 810 818
66. John WG Lamb EJ The Maillard or browning reaction in diabetes Eye 1993 7 Pt 2 230 237
67. Kapp C World Health Report charts way forward on CV disease prevention Lancet Neurol 2002 1 461
68. Katz PP Wirthlin MR Jr. Szpunar SM Selby JV Sepe SJ Showstack JA Epidemiology and prevention of periodontal disease in individuals with diabetes Diabetes Care 1991 14 375 385
69. Kinane DF Aetiology and pathogenesis of periodontal disease Ann R Australas Coll Dent Surg 2000 15 42 50
70. Kishimoto T Akira S Taga T Interleukin-6 and its receptor: a paradigm for cytokines Science 1992 258 593 597
71. Klein RL Wohltmann HJ Lopes-Virella MF Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type I diabetic patients with human monocyte-derived macrophages Diabetes 1992 41 1301 1307
72. Kosaki A Hasegawa T Kimura T Iida K Hitomi J Matsubara H Mori Y Okigaki M Toyoda N Masaki H Inoue-Shibata M Nishikawa M Iwasaka T Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes J Clin Endocrinol Metab 2004 89 5423 5428
73. Kottra CJ Infection in the compromised host - an overview Heart Lung 1983 12 10 14
74. Krakauer T Molecular therapeutic targets in inflammation. cyclooxygenase and NF-kappaB Curr Drug Targets Inflamm Allergy 2004 3 317 324
75. Krentz AJ Lipoprotein abnormalities and their consequences for patients with type 2 diabetes Diabetes Obes Metab 2003 5 Suppl. 1 S19 S27
76. Laakso M Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes Prim Care 1999 26 829 839
77. Lalla E Lamster IB Drury S Fu C Schmidt AM Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis Periodontol 2000 2000 23 50 62
78. Lamharzi N Renard CB Kramer F Pennathur S Heinecke JW Chait A Bornfeldt KE Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL Diabetes 2004 53 3217 3225
79. Larkin JG Frier BM Ireland JT Diabetes mellitus and infection Postgrad Med J 1985 61 233 237
80. + channel-mediated vasodilation Vascul Pharmacol 2002 38 43 49
81. Loe H Periodontal disease as we approach the year 2000 J Periodontol 1994 65 464 467
82. Lopes-Virella MF Virella G Immune mechanisms of atherosclerosis in diabetes mellitus Diabetes 1992 41 Suppl. 2 86 91
83. Lovegrove JM Dental plaque revisited: bacteria associated with periodontal disease J N Z Soc Periodontol 2004 87 7 21
84. Lundberg V Stegmayr B Asplund K Eliasson M Huhtasaari F Diabetes as a risk factor for myocardial infarction: population and gender perspectives J Intern Med 1997 241 485 492
85. Lyons TJ Lipoprotein glycation and its metabolic consequences Diabetes 1992 41 Suppl. 2 67 73
86. Malavige GN Does leptin resistance contribute to infections in patients with diabetes? Mol Pathol 2003 56 248
87. Mamputu JC Renier G Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression. inhibitory effect of antioxidants J Leukoc Biol 2004 75 1062 1069
88. Mandell RL Dirienzo J Kent R Joshipura K Haber J Microbiology of healthy and diseased periodontal sites in poorly controlled insulin dependent diabetics J Periodontol 1992 63 274 279
89. Marinkovic S Jahreis GP Wong GG Baumann H IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo J Immunol 1989 142 808 812
90. Marx N Walcher D Ivanova N Rautzenberg K Jung A Friedl R Hombach V de Caterina R Basta G Wautier MP Wautiers JL Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products Diabetes 2004 53 2662 2668
91. Mattila KJ Viral and bacterial infections in patients with acute myocardial infarction J Intern Med 1989 225 293 296
92. May MJ Ghosh S Rel/NF-kappa B and I kappa B proteins: an overview Semin Cancer Biol 1997 8 63 73
93. Michalek SM Katz J Childers NK Martin M Ballovetz DF Microbial/host interactions: mechanisms involved in host responses to microbial antigens Immunol Res 2002 26 223 234
94. Miller LS Manwell MA Newbold D Reding ME Rasheed A Blodgett J Kornman KS The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases J Periodontol 1992 63 843 848
95. Miranda LP Tao T Jones A Chernushevich I Standing KG Geczy CL Alewood PF Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE) FEBS Lett 2001 488 85 90
96. Miyazaki Y Pipek R Mandarino LJ DeFronzo RA Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients Int J Obes Relat Metab Disord 2003 27 88 94
97. Molvig J Baek L Christensen P Manogue KR Vlassara H Platz P Nielsen LS Svejgaard A Nerup J Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences Scand J Immunol 1988 27 705 716
98. Monnier VM Glomb M Elgawish A Sell DR The mechanism of collagen cross-linking in diabetes: a puzzle nearing resolution Diabetes 1996 45 Suppl. 3 S67 S72
99. Moore PA Weyant RJ Mongelluzzo MB Myers DE Rossie K Guggenheimer J Block HM Huber H Orchard T Type 1 diabetes mellitus and oral health: assessment of periodontal disease J Periodontol 1999 70 409 417
100. Morel DW Hessler JR Chisolm GM Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid J Lipid Res 1983 24 1070 1076
101. Muhammad S Epidemiology of diabetes and obesity in the United States Compend Contin Educ Dent 2004 25 195 198 200 202, quiz 204
102. Musson RA Shafran H Henson PM Intracellular levels and stimulated release of lysosomal enzymes from human peripheral blood monocytes and monocyte-derived macrophages J Reticuloendothel Soc 1980 28 249 264
103. Muzio M Natoli G Saccani S Levrero M Mantovani A The human toll signaling pathway. divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) J Exp Med 1998 187 2097 2101
104. Nakamura Y Horii Y Nishino T Shiiki H Sakaguchi Y Kagoshima T Dohi K Makita Z Vlassara H Bucala R Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus Am J Pathol 1993 143 1649 1656
105. Nathan CF Murray HW Cohn ZA The macrophage as an effector cell N Engl J Med 1980 303 622 626
106. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Diabetes across the United States. In: National Diabetes Information Clearinghouse (NDIC).[WWW document]..
107. Neeper M Schmidt AM Brett J Yan SD Wang F Pan YC Elliston K Stern D Shaw A Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J Biol Chem 1992 267 14998 15004
108. Neil A Diabetes and cardiovascular disease Diabetes Obes Metab 2003 5 Suppl. 1 S11 S18
109. Nerup J Mandrup-Poulsen T Molvig J The HLA-IDDM association: implications for etiology and pathogenesis of IDDM Diabetes Metab Rev 1987 3 779 802
110. Nesto R CHD. a major burden in type 2 diabetes Acta Diabetol 2001 38 Suppl. 1 S3 S8
111. Nomoto K Oguchi S Watanabe I Kushiro T Kanmatsuse K Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1 J Cardiol 2003 42 201 206
112. O'Brien KD Alpers CE Hokanson JE Wang S Chait A Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein Circulation 1996 94 1216 1225
113. O'Neill LA The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense Biochem Soc Trans 2000 28 557 563
114. Page RC Offenbacher S Schroeder HE Seymour GJ Kornman KS Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions Periodontol 2000 1997 14 216 248
115. Papapanou PN Epidemiology of periodontal diseases: an update J Int Acad Periodontol 1999 1 110 116
116. Peppa M Uribarri J Vlassara H Advanced glycoxidation. A new risk factor for cardiovascular disease? Cardiovasc Toxicol 2002 2 275 287
117. Pirola L Johnston AM Van Obberghen E Modulation of insulin action Diabetologia 2004 47 170 184
118. Preshaw PM Seymour RA Heasman PA Current concepts in periodontal pathogenesis Dent Update 2004 31 574 578
119. Pugin J Heumann ID Tomasz A Kravchenko VV Akamatsu Y Nishijima M Glauser MP Tobias PS Ulevitch RJ CD14 is a pattern recognition receptor Immunity 1994 1 509 516
120. Pussinen PJ Mattila K Periodontal infections and atherosclerosis: mere associations? Curr Opin Lipidol 2004 15 583 588
121. Qi M Miyakawa H Kuramitsu HK Porphyromonas gingivalis induces murine macrophage foam cell formation Microb Pathog 2003 35 259 267
122. Quinn L Educating patients with diabetes about cardiovascular disease risk Prog Cardiovasc Nurs 2004 19 107 113
123. Radulescu L Stancu C Antohe F Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins Med Sci Monit 2004 10 BR207 214
124. Rashid G Benchetrit S Fishman D Bernheim J Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells Kidney Int 2004 66 1099 1106
125. Raynes JG The acute phase response Biochem Soc Trans 1994 22 69 74
126. Reaven P Metabolic syndrome J Insur Med 2004 36 132 142
127. Renard CB Kramer F Johansson F Lamharzi N Tannock LR von Herrath MG Chait A Bornfeldt KE Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions J Clin Invest 2004 114 659 668
128. Rizvi AA Type 2 diabetes: epidemiologic trends, evolving pathogenic concepts, and recent changes in therapeutic approach South Med J 2004 97 1079 1087
129. Rodel J Prochnau D Prager K Pentcheva E Hartmann M Straube E Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae FEMS Immunol Med Microbiol 2003 38 159 164
130. Ruan H Hacohen N Golub TR Van Parijs L Lodish HF Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory Diabetes 2002 51 1319 1336
131. Ryseck RP Weih F Carrasco D Bravo R RelB, a member of the Rel/NF-kappa B family of transcription factors Braz J Med Biol Res 1996 29 895 903
132. Salvi GE Beck JD Offenbacher S PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression Ann Periodontol 1998 3 40 50
133. Salvi GE Lawrence HP Offenbacher S Beck JD Influence of risk factors on the pathogenesis of periodontitis Periodontol 2000 1997 14 173 201
134. Salvi GE Yalda B Collins JG Jones BH Smith FW Arnold RR Offenbacher S Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients J Periodontol 1997 68 127 135
135. Santamaria P Gehrz RC Bryan MK Barbosa JJ Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level J Immunol 1989 143 913 922
136. Schmidt AM Hasu M Popov D Zhang JH Chen J Yan SD Brett J Cao R Kuwabara K Costache G et al. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins Proc Natl Acad Sci U S A 1994 91 8807 8811
137. Schmidt AM Hori O Cao R Yan SD Brett J Wautier JL Ogawa S Kuwabara K Matsumoto M Stern D RAGE: a novel cellular receptor for advanced glycation end products Diabetes 1996 45 Suppl. 3 S77 S80
138. Schmidt AM Yan SD Brett J Mora R Nowygrod R Stern D Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products J Clin Invest 1993 91 2155 2168
139. Schmidt AM Yan SD Wautier JL Stern D Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circ Res 1999 84 489 497
140. Schumacher M Eber B Tatzber F Kaufmann P Esterbauer H Klein W LDL oxidation and coronary atherosclerosis Lancet 1992 340 123
141. Semb H Peterson J Tavernier J Olivecrona T Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo J Biol Chem 1987 262 8390 8394
142. Semenkovich CF Heinecke JW The mystery of diabetes and atherosclerosis: time for a new plot Diabetes 1997 46 327 334
143. Shapira L Warbington M Van Dyke TE TNF alpha and IL-1 beta in serum of LJP patients with normal and defective neutrophil chemotaxis J Periodontal Res 1994 29 371 373
144. Sigurdardottir V Fagerberg B Hulthe J Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study) J Intern Med 2002 252 440 447
145. Slade GD Offenbacher S Beck JD Heiss G Pankow JS Acute-phase inflammatory response to periodontal disease in the US population J Dent Res 2000 79 49 57
146. Socransky SS Haffajee AD Cugini MA Smith C Kent RL Jr. Microbial complexes in subgingival plaque J Clin Periodontol 1998 25 34 144
147. Stephens JW Ambler G Vallance P Betteridge DJ Humphries SE Hurel SJ Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory? Eur J Cardiovasc Prev Rehabil 2004 11 521 528
148. Storz P Doppler H Wernig A Pfizenmaier K Muller G Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake Eur J Biochem 1999 266 17 25
149. Streja D Metabolic syndrome and other factors associated with increased risk of diabetes Clin Cornerstone 2004 6 Suppl. 3 S14 S29
150. Taguchi A Blood DC del Toro G Canet A Lee DC Qu W Tanji N Lu Y Lalla E Fu C Hofmann MA Kislinger T Ingram M Lu A Tanaka H Hori O Ogawa S Stern DM Schmidt AM Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 2000 405 354 360
151. Tanimoto K Ohno S Fujimoto K Honda K Ijuin C Tanaka N Doi T Nakahara M Tanne K Proinflammatory cytokines regulate the gene expression of hyaluronic acid synthetase in cultured rabbit synovial membrane cells Connect Tissue Res 2001 42 187 195
152. Taylor GW Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective Ann Periodontol 2001 6 99 112
153. Taylor GW Burt BA Becker MP Genco RJ Shlossman M Glycemic control and alveolar bone loss progression in type 2 diabetes Ann Periodontol 1998 3 30 39
154. Thanos D Maniatis T NF-kappa B: a lesson in family values Cell 1995 80 529 532
155. Tilg H Dinarello CA Mier JW IL-6 and APPs: anti-inflammatory and immunosuppressive mediators Immunol Today 1997 18 428 432
156. Tsai C Hayes C Taylor GW Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population Community Dent Oral Epidemiol 2002 30 182 192
157. Tsilibary EC Charonis AS Reger LA Wohlhueter RM Furcht LT The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen J Biol Chem 1988 263 4302 4308
158. Vaziri ND Oxidative stress in uremia: nature, mechanisms, and potential consequences Semin Nephrol 2004 24 469 473
159. Virella G Atchley D Koskinen S Zheng D Lopes-Virella MF Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL Clin Immunol 2002 105 81 92
160. Vlassara H Recent progress on the biologic and clinical significance of advanced glycosylation end products J Lab Clin Med 1994 124 19 30
161. Wautier JL Schmidt AM Protein glycation: a firm link to endothelial cell dysfunction Circ Res 2004 95 233 238
162. Weitzman S Wang C Rosamond WD Chambless LE Cooper LS Shahar E Goff DC Is diabetes an independent risk factor for mortality after myocardial infarction? The ARIC (Atherosclerosis Risk in Communities) Surveillance Study Acta Diabetol 2004 41 77 83
163. Wesche H Henzel WJ Shillinglaw W Li S Cao Z MyD88: an adapter that recruits IRAK to the IL-1 receptor complex Immunity 1997 7 837 847
164. Winer N Sowers JR Epidemiology of diabetes J Clin Pharmacol 2004 44 397 405
165. Wogensen LD Mandrup-Poulsen T Markholst H Molvig J Lernmark A Holst JJ Dinarello CA Nerup J Interleukin-1 potentiates glucose stimulated insulin release in the isolated perfused pancreas Acta Endocrinol (Copenh) 1988 117 302 306
166. Wolffenbuttel BH Boulanger CM Crijns FR Huijberts MS Poitevin P Swennen GN Vasan S Egan JJ Ulrich P Cerami A Levy BI Breakers of advanced glycation end products restore large artery properties in experimental diabetes Proc Natl Acad Sci U S A 1998 95 4630 4634
167. Wulczyn FG Krappmann D Scheidereit C The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation J Mol Med 1996 74 749 769
168. Yalda B Offenbacher S Collins JG Diabetes as a modifier of periodontal disease expression Periodontol 2000 1994 6 37 49
169. Yeh CH Sturgis L Haidacher J Zhang XN Sherwood SJ Bjercke RJ Juhasz O Crow MT Tilton RG Denner L Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion Diabetes 2001 50 1495 1504
170. Yet SF Melo LG Layne MD Perrella MA Heme oxygenase 1 in regulation of inflammation and oxidative damage Methods Enzymol 2002 353 163 176
171. Yosefy C Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved? Acta Diabetol 2003 40 Suppl. 2 S380 S388
172. Yuan K Chang CJ Hsu PC Sun HS Tseng CC Wang JR Detection of putative periodontal pathogens in non-insulin-dependent diabetes mellitus and non-diabetes mellitus by polymerase chain reaction J Periodontal Res 2001 36 18 24
173. Zimmet PZ McCarty DJ de Courten MP The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome J Diabetes Complications 1997 11 60 68